Overview

Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of three different long-term treatment strategies of reflux disease in primary care setting.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Antacids
Esomeprazole